floxuridine

floxuridine is commonly administered via hepatic arterial infusion for liver cancer treatment.

the recommended floxuridine dosage varies based on the patient's body surface area.

floxuridine chemotherapy may cause severe myelosuppression in some patients.

physicians must monitor floxuridine toxicity levels during treatment.

floxuridine infusion is typically given over several hours.

clinical trials have shown floxuridine effectiveness in treating metastatic colorectal cancer.

patients receiving floxuridine therapy require regular blood count monitoring.

floxuridine metabolism occurs primarily in the liver.

the side effects of floxuridine include nausea, vomiting, and diarrhea.

floxuridine can be combined with other chemotherapeutic agents for enhanced efficacy.

healthcare providers should explain floxuridine risks before initiating treatment.

floxuridine hepatic arterial infusion delivers the drug directly to liver tumors.